Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?

Coronary artery aneurysms (CAAs) are uncommon in coronary angiography, and left main coronary artery aneurysms are rare. There is no consensus for the treatment of CAAs. A young patient with left coronary artery aneurysm diagnosed by coronary angiography and with recurrent acute myocardial infarctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Quanxiang, Ning, Libing, Jian, Yu, Yang, Wencong, Yuan, Qinghua, Du, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196985/
https://www.ncbi.nlm.nih.gov/pubmed/32373178
http://dx.doi.org/10.1155/2020/5073814
Descripción
Sumario:Coronary artery aneurysms (CAAs) are uncommon in coronary angiography, and left main coronary artery aneurysms are rare. There is no consensus for the treatment of CAAs. A young patient with left coronary artery aneurysm diagnosed by coronary angiography and with recurrent acute myocardial infarction was treated with rivaroxaban and aspirin. The patient had no angina for 6 months. Novel oral anticoagulants combined with antiplatelet agents may be appropriate for the treatment of CAAs.

Ejemplares similares